Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

Recent first-line randomized controlled trials (RCTs) for patients with diffuse large B-cell lymphoma (DLBCL) have shown negative results, which may be due in part to onerous eligibility criteria limiting enrollment of poor-risk patients who require immediate treatment. We conducted a Delphi-method...

Descripción completa

Detalles Bibliográficos
Autores principales: Harkins, R. Andrew, Patel, Sharvil P., Lee, Michelle J., Switchenko, Jeffrey M., Ansell, Stephen M., Bartlett, Nancy L., Blum, Kristie A., Cashen, Amanda F., Casulo, Carla, Friedberg, Jonathan W., Johnston, Patrick B., Kahl, Brad S., Leonard, John P., Link, Brian K., Lossos, Izidore S., Martin, Peter, Maurer, Matt J., Mehta-Shah, Neha, Reagan, Patrick M., Westin, Jason R., Koff, Jean L., Flowers, Christopher R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092417/
https://www.ncbi.nlm.nih.gov/pubmed/35100356
http://dx.doi.org/10.1182/bloodadvances.2021006504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092417/
https://www.ncbi.nlm.nih.gov/pubmed/35100356
http://dx.doi.org/10.1182/bloodadvances.2021006504

Ejemplares similares